244 results on '"AND FUSCO, A."'
Search Results
2. Correction to: Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas
3. Wnt4 inhibits cell motility induced by oncogenic Ras
4. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis
5. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
6. Upregulation of miR-21 by Ras in vivo and its role in tumor growth
7. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
8. CCDC6 represses CREB1 activity by recruiting histone deacetylase 1 and protein phosphatase 1
9. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
10. Regulation of microRNA expression by HMGA1 proteins
11. HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas
12. Specific microRNAs are downregulated in human thyroid anaplastic carcinomas
13. Involvement of H4(D10S170) protein in ATM-dependent response to DNA damage
14. UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas
15. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas
16. Erratum: Regulation of microRNA expression by HMGA1 proteins
17. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death
18. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas
19. The rat tyrosine phosphatase η increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue
20. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors
21. The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis
22. Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors
23. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas
24. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells
25. Critical role of cyclin D3 in TSH-dependent growth of thyrocytes and in hyperproliferative diseases of the thyroid gland
26. Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells
27. Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes
28. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity
29. HMGA1 and HMGA2 protein expression in mouse spermatogenesis
30. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas
31. Thyroid cell transformation requires the expression of the HMGA1 proteins
32. Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27kip 1
33. RET/PTC1 oncogene signaling in PC Cl 3 thyroid cells requires the small GTP-binding protein Rho
34. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth
35. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas
36. The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane
37. The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret
38. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium
39. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1
40. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
41. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene
42. Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines
43. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts
44. Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo
45. Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret
46. Simian virus 40-like DNA sequences in human papillary thyroid carcinomas
47. HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas
48. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization
49. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression
50. Erratum: HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.